Compare AKRO & RIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AKRO | RIG |
|---|---|---|
| Founded | 2017 | 1926 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 4.3B |
| IPO Year | 2019 | 1993 |
| Metric | AKRO | RIG |
|---|---|---|
| Price | $54.55 | $4.28 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 9 |
| Target Price | ★ $73.56 | $4.41 |
| AVG Volume (30 Days) | 2.4M | ★ 33.3M |
| Earning Date | 11-07-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $3,874,000,000.00 |
| Revenue This Year | N/A | $12.54 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 16.93 |
| 52 Week Low | $21.34 | $1.97 |
| 52 Week High | $58.40 | $4.56 |
| Indicator | AKRO | RIG |
|---|---|---|
| Relative Strength Index (RSI) | 68.63 | 56.77 |
| Support Level | $54.30 | $4.37 |
| Resistance Level | $54.70 | $4.56 |
| Average True Range (ATR) | 0.17 | 0.20 |
| MACD | -0.10 | -0.01 |
| Stochastic Oscillator | 71.07 | 68.19 |
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
Transocean Ltd. is an international provider of offshore contract drilling services for oil and gas wells. Its segment involves contracting mobile offshore drilling rigs, related equipment, and work crews to drill oil and gas wells.